Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A challenging case of cerebellar ataxia associated with oro facial dominant chorea.
Larget A, Rafiq M, Barbosa R, Bonneville F, Bost C, Fabbri M, Leung C, Mirabel H, Rigal Milongo E, Pariente J, Ory-Magne F. Larget A, et al. Among authors: ory magne f. Parkinsonism Relat Disord. 2024 Nov 16:107189. doi: 10.1016/j.parkreldis.2024.107189. Online ahead of print. Parkinsonism Relat Disord. 2024. PMID: 39578188 Free article. No abstract available.
Survey on Parkinson's Disease Diagnosis Impact: Patients, Caregivers and Health Care Professionals' Perspectives.
Dodaj S, Fabbri M, Doe de Maindreville A, Foubert-Samier A, Toussaint MC, Carriere N, Lopez J, Giroud M, Sattler V, Gerdelat A, Baille G, Turc JD, Barthelemy C, Scotto D Apollonia C, Fabre MH, Eytier E, Thiriez C, Fluchère F, Ory-Magne F. Dodaj S, et al. Among authors: ory magne f. J Clin Med. 2024 Jul 14;13(14):4118. doi: 10.3390/jcm13144118. J Clin Med. 2024. PMID: 39064158 Free PMC article.
Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial.
Brefel-Courbon C, Harroch E, Marques A, Devos D, Thalamas C, Rousseau V, Ory-Magne F, Fabbri M, Maltête D, Rouaud T, Drapier S, Tir M, Thobois S, Salhi H, Corvol JC, Castelnovo G, Lagha-Boukbiza O, Fluchère F, Frismand S, Ansquer S, Sommet A, Rascol O. Brefel-Courbon C, et al. Among authors: ory magne f. Mov Disord. 2024 Sep;39(9):1533-1543. doi: 10.1002/mds.29878. Epub 2024 Jun 8. Mov Disord. 2024. PMID: 38850081 Clinical Trial.
Trial of Lixisenatide in Early Parkinson's Disease.
Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O; LIXIPARK Study Group. Meissner WG, et al. Among authors: ory magne f. N Engl J Med. 2024 Apr 4;390(13):1176-1185. doi: 10.1056/NEJMoa2312323. N Engl J Med. 2024. PMID: 38598572 Clinical Trial.
Amantadine use in the French prospective NS-Park cohort.
Fabbri M, Rousseau V, Corvol JC, Sommet A, Tubach F, De Rycke Y, Bertille N, Selvarasa Y, Carvalho S, Chaigneau V, Brefel-Courbon C, Ory-Magne F, Tessier S, Tir M, Bereau M, Meissner WG, Thiriez C, Marques A, Remy P, Schneider V, Moro E, Defebvre L, Houeto JL, Prange S, Eusebio A, Geny C, Frismand S, Damier P, Reuther CG, Castelnovo G, Benatru I, De Maindreville AD, Drapier S, Maltête D, Lagha-Boukbiza O, Rascol O; French N. S.-Park network. Fabbri M, et al. Among authors: ory magne f. J Neural Transm (Vienna). 2024 Jul;131(7):799-811. doi: 10.1007/s00702-024-02772-4. Epub 2024 Apr 5. J Neural Transm (Vienna). 2024. PMID: 38578434
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.
Barbosa RP, Moreau C, Rolland AS, Rascol O, Brefel-Courbon C, Ory-Magne F, Bastos P, de Barros A, Hainque E, Rouaud T, Marques A, Eusebio A, Benatru I, Drapier S, Guehl D, Maltete D, Tranchant C, Wirth T, Giordana C, Tir M, Thobois S, Hopes L, Hubsch C, Jarraya B, Corvol JC, Bereau M, Devos D, Fabbri M; PREDISTIM Group. Barbosa RP, et al. Among authors: ory magne f. J Neurol. 2024 May;271(5):2582-2595. doi: 10.1007/s00415-023-12162-7. Epub 2024 Feb 9. J Neurol. 2024. PMID: 38334813
Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study.
Wirth T, Goetsch T, Corvol JC, Roze E, Mariani LL, Vidailhet M, Grabli D, Mallet L, Pelissolo A, Rascol O, Brefel-Courbon C, Ory-Magne F, Arbus C, Bekadar S, Krystkowiak P, Marques A, Llorca M, Krack P, Castrioto A, Fraix V, Maltete D, Defebvre L, Kreisler A, Houeto JL, Tranchant C, Meyer N, Anheim M. Wirth T, et al. Among authors: ory magne f. J Neurol. 2024 May;271(5):2412-2422. doi: 10.1007/s00415-023-12170-7. Epub 2024 Jan 12. J Neurol. 2024. PMID: 38214756
Discontinuation rate and long-term adverse events path of apomorphine infusion in advanced Parkinson's disease patients.
Camgrand E, Christine BC, Harroch E, Chouquet C, Barthelemy C, Ory-Magne F, Leung C, Barbosa RP, Rascol O, Fabbri M. Camgrand E, et al. Among authors: ory magne f. Parkinsonism Relat Disord. 2023 Nov;116:105859. doi: 10.1016/j.parkreldis.2023.105859. Epub 2023 Sep 28. Parkinsonism Relat Disord. 2023. PMID: 37788512 No abstract available.
82 results